Associate Professor
To see if Kit W. Tam is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Gastrointestinal Medicine
Colorectal (Colon)
Esophageal (Throat)
Liver
Pancreas
Stomach
UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817
Phone: 916-734-5959
Dr. Tam participates in clinical trials pertaining to oncology malignancies of gastrointestinal origin.
Dr. Tam's academic interests are developing education materials to the target patient population for Health And Life Organization (HALO) Sacramento clinics with the goal to enhance cancer screening and improve survival outcome among Asian Americans, Native Hawaiians and Pacific Islanders (AANHPIs).
Hematology and Oncology
B.A., Public Health, Johns Hopkins University Bloomberg, Baltimore MD 2000
M.D., University of Texas-Southwestern Medical School, Dallas TX 2008
M.H.S., Environmental Science, Johns Hopkins University Bloomberg School of Public Health, Baltimore MD 2002
Internal Medicine, University of Texas Southwestern Medical Center, Dallas TX 2009-2010
Internal Medicine, University of Texas Southwestern Medical Center, Dallas TX 2010-2012
Hematology Oncology, UC Davis Medical Center, Sacramento CA 2013-2016
1st place at the North Texas Chapter, Resident Poster Presentation at the American College of Physicians Annual Meeting, 2012
Chen H, Nguyen KNB, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, Halabi WJ, Monjazeb AM, Rong Y. Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer. Pract Radiat Oncol. 2020 Sep-Oct;10(5):e372-e377. doi:10.1016/j.prro.2019.12.007. Epub 2019 Dec 20. PMID:31866577.
Demisse R, Damle N, Kim E, Gong J, Fakih M, Eng C, Oesterich L, McKenny M, Ji J, Liu J, Louie R, Tam K, Gholami S, Halabi W, Monjazeb A, Dayyani F, Cho M. Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series. J Natl Compr Canc Netw. 2020 Jul;18(7):798-804. doi:10.6004/jnccn.2020.7558. PMID:32634770.
Judge SJ, Ji J, Liu J, Kaur M, Kim E, Gong J, Tam KW, Kirane AR, Gholami S, Canter RJ, Bold RJ, Gangi A, Fakih M, Cho M. The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report. Front Oncol. 2020 Apr 21;10:581. doi:10.3389/fonc.2020.00581. PMID:32373540.
Gong J, Robertson MD, Kim E, Fakih M, Schrock AB, Tam KW, Burugapalli B, Monjazeb AM, Hendifar AE, Hitchins M, Klempner SJ, Cho M. Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden. Clin Colorectal Cancer. 2019 Dec;18(4):307-309. doi:10.1016/j.clcc.2019.08.001. Epub 2019 Sep 4. PMID:31563511.
Tam KW, Zhang W, Soh J, Stastny V, Chen M, Sun H, Thu K, Rios JJ, Yang C, Marconett CN, Selamat SA, Laird-Offringa IA, Taguchi A, Hanash S, Shames D, Ma X, Zhang MQ, Lam WL, Gazdar A. CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer. J Thorac Oncol. 2013 Nov;8(11):1378-88. doi:10.1097/JTO.0b013e3182a46c0c. PMID:24077454.